VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
40 hedge funds and large institutions have $42.8M invested in Vincerx Pharma, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
40
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.06M | |
| 2 | +$3.09M | |
| 3 | +$777K | |
| 4 |
EP
Eversept Partners
New York
|
+$403K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$362K |
Top Sellers
| 1 | -$5.46M | |
| 2 | -$1.93M | |
| 3 | -$1.3M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$1.2M |
| 5 |
Renaissance Technologies
New York
|
-$276K |